Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial”.
Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou +31 more
Rafet Başar, Sunil Acharya, Yu-Sung Hsu, Pinghua Liu, Deqiang Zhang +53 more